Sielos veidrodis, MB - financials and debts

Company age: 5 y. 11 mo.

Update

Sielos veidrodis - Company finances

EUR
2020
From: 2020-10-29
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 3,200 46,372 27,587 43,175 59,381 52,977
Profit before tax 400 17,866 -2,709 8,398 -664 12,447
Net profit 400 16,972 -2,709 8,108 -664 11,693
Equity 450 17,472 14,764 8,208 1,508 13,201
Liabilities - - 2,354 3,230 14,551 3,708
Non-current assets 0 427 575 1,530 878 1,383
Current assets 1,269 19,987 16,543 9,908 15,181 15,526
Total assets 1,269 20,414 17,118 11,438 16,059 16,909
Taxes paid
STI taxes - - - 533 7,535 8,824
Financial indicators
Revenue change y/y - +1349.1% -40.5% +56.5% +37.5% -10.8%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 31.5% 83.1% -15.8% 70.9% -4.1% 69.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 88.9% 97.1% -18.3% 98.8% -44.0% 88.6%
Profit margin Net profit margin. Shows the overall profitability of the company. 12.5% 36.6% -9.8% 18.8% -1.1% 22.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 12.5% 38.5% -9.8% 19.5% -1.1% 23.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - 0.2 0.4 9.6 0.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 3,200 46,372 - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Sielos veidrodis - Social security debts

From To Debt, €
2026-09-01 2026-09-02 80.48
2025-11-01 2025-11-30 72.45
2025-04-01 2025-04-30 72.45
2024-06-03 2024-06-30 64.50

Sielos veidrodis - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company Sielos veidrodis is: 0 €

From To Overdue, €
2026-08-28 2026-09-02 0.2
2026-07-30 2026-08-13 0.2
2026-06-28 2026-07-07 0.2
2026-03-29 2026-04-02 0.26
2025-10-30 2025-11-14 0.22
2025-09-28 2025-10-23 0.22
2025-09-25 2025-09-25 0.22
2025-09-17 2025-09-24 45.11
2025-07-28 2025-08-11 3.0
2025-07-15 2025-07-24 3.0
2025-02-25 2025-02-26 0.16
2025-02-21 2025-02-24 0.1
2025-02-20 2025-02-20 104.1
2025-01-30 2025-02-19 0.1
2024-12-30 2025-01-24 0.1
2024-11-28 2024-12-19 0.1
2024-10-01 2024-10-16 1.2

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Sielos veidrodis, MB (code 305649764) is a Lithuanian small partnership engaged in traditional, complementary and alternative medicine activities. In the latest financial year, 2025, the company generated revenue of EUR 53.0K and net profit of EUR 11.7K, corresponding to a profit margin of 22.1%. Revenue decreased by 10.8% year on year after peaking at EUR 59.4K in 2024, but profitability recovered strongly from a small loss of EUR 664 in 2024. In 2023, the business recorded revenue of EUR 43.2K and net profit of EUR 8.1K, showing an overall two-year revenue increase of 22.7% from 2023 to 2025. The balance sheet remained modest in size, with total assets of EUR 16.9K, equity of EUR 13.2K and liabilities of EUR 3.7K at the end of 2025. Equity represented 78.1% of assets, and debt to equity stood at 0.28. Asset turnover was 3.13x, indicating that the asset base supported relatively high sales activity. The reported return on equity was 88.6% and return on assets 69.2% for 2025.